PubMed Health⌕ Search

Biomedical subjects

Paul A Gaudio

Publications and source records attributed to Paul A Gaudio.

2 recordsLinked to original sources

Update on ocular syphilis.

PURPOSE OF REVIEW: The present review updates the reader on publications from the past 5 years relevant to ocular syphilis. RECENT FINDINGS: Articles from this period are easily grouped into three categories: descriptions of syphilitic ocular manifestations, ocular syphilis in the setting of HIV infection, and treatment of syphilitic ocular disease. While all of the entities described were previously recognized, many are unusual and their description in connection with syphilis is a reminder to be vigilant for this uncommon but everpresent disease. Ocular syphilis can be more severe in patients with HIV infection who are not taking highly active antiretroviral therapy, while with this treatment syphilis is an increasingly likely cause of ocular inflammation. Ocular syphilis should be treated like neurosyphilis, with daily intravenous or intramuscular penicillin for 2 weeks. The prevalence of syphilis has increased markedly in the past 5 years, most notably among men who have sex with men. The fluorescent treponemal antibody assay and similar tests remain the appropriate diagnostic tests for syphilis in patients with ocular inflammation. SUMMARY: Syphilis lingers on the differential diagnosis of all forms of ocular inflammation and should be considered when evaluating such patients.

Anti-Bacterial Agents↗

A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.

PURPOSE: To review the published laboratory and clinical studies pertaining to the efficacy of corticosteroids in the treatment of intraocular inflammation. METHODS: A Pubmed computer search was conducted of all publications focusing on the efficacy of corticosteroids in treating ocular inflammation, with an additional search of pertinent citations culled from these articles. RESULTS: Experimental evidence has established the efficacy of corticosteroid eyedrops in treating intraocular inflammation. The effectiveness of periocular corticosteroid injections as well as of systemic corticosteroids is supported by extensive clinical experience, although placebo-controlled trials are lacking. Few studies have documented differences in efficacy between the common corticosteroid agents or between the different routes of administration. Subconjunctival injection appears to achieve higher intraocular corticosteroid levels than do other routes of periocular injection or systemic therapy. Clinical experience with intravitreous corticosteroid injection is insufficient to firmly attest to its efficacy or safety. CONCLUSION: The efficacy of corticosteroids in treating intraocular inflammation is based on limited experimental evidence and considerable clinical experience.

Databases, Factual↗